Scientists identify mechanisms in aspirin that help protect against cancer

Scientists identify mechanisms in aspirin that help protect against cancer
Tracks/footprints of white blood cells as they find early cancer cells (green) in the zebrafish larvae

(Medical Xpress) -- Recent clinical studies have indicated that long-term usage of non-steroidal anti-inflammatory drugs (NSAIDs) such as aspirin can significantly reduce the risk of various cancers — some up to 30 per cent.  New findings, published today in Current Biology, provides fresh evidence into their protective properties.

Until now, the processes that underpin these protective effects were unclear but researchers from the Universities of Bristol and Sheffield have now identified how long-term use and low doses of may help to stave off cancer. 

Using translucent zebrafish larvae the researchers were able to visualise how white interact with the early cancer cell formation as they arise in tissues. Previous studies have shown that are less likely to divide if the white blood cells can be prevented from contacting the precursor cancer cells, suggesting that white blood cells – the immune cells – have the ability to promote disease by providing some kind of growth signal.

Lead author, Dr Yi Feng from Bristol's School of Biochemistry, found that these white blood cells, whose normal role is to fight off infections, supply the cancer cells with essential survival factors and identified one of these key factors as prostaglandin – PGE2.  If the immune cells are genetically deleted then the cancer cells cannot grow but they begin growing again if the researchers feed them PGE2. 

The results show that at least in part, taking drugs like , which are generally taken for cardiovascular problems, prevent the development of cancer by starving the cancer cells of this source of white blood cell early-growth support.

Paul Martin, Professor of Cell Biology at the University of Bristol’s Schools of Biochemistry and Physiology and Pharmacology and senior author of this study, said: “These findings are important as they help explain the underlying cellular processes at work which could be used to develop potential new therapies for eliminating early-stage cancer in humans.”

More information: The Wellcome Trust funded study, entitled Live Imaging of Tumor Initiation in Zebrafish Larvae Reveals a Trophic Role for Leukocyte-Derived PGE2 is published today [31 May] in Current Biology.

Related Stories

Zebrafish provide new hope for cancer treatment

Dec 14, 2010

The imaging of tumour growth in zebrafish has revealed for the first time how newly formed cancer cells have the capacity to co-opt the immune system into spreading the disease, leading the way for investigations into potential ...

New role for natural killers

Aug 27, 2008

Scientists at the University of York have discovered a new role for a population of white blood cells, which may lead to improved treatments for chronic infections and cancer.

Scientists expose important new weak spot in cancer cells

Dec 05, 2011

(Medical Xpress) -- Cancer Research UK scientists have discovered that cancer cells can ‘bag up and bin’ a toxic protein to cheat death – revealing a new Achilles heel in cancer cells that could be targeted ...

Recommended for you

All-clear for nonlinear optical imaging

4 hours ago

High power femto-second laser pulses used for in vivo nonlinear optical imaging can form DNA products, which may lead to carcinogenesis. A modified cancer risk model now shows that the cancer risk is negligible ...

User comments